TSOI (Therapeutic Solutions International) Shares Outstanding (EOP): 5,057.15 Mil (As of Sep. 2024)


What is Therapeutic Solutions International Shares Outstanding (EOP)?

Therapeutic Solutions International TSOI -99.00% Shares Outstanding (EOP) is 5,057.15 Mil as of Sep. 2024.

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. Therapeutic Solutions International's shares outstanding for the quarter that ended in Sep. 2024 was 5,057.15 Mil.

Therapeutic Solutions International's quarterly shares outstanding increased from Jun. 2024 (4,659.02 Mil) to Sep. 2024 (5,057.15 Mil). It means Therapeutic Solutions International issued new shares from Jun. 2024 to Sep. 2024 .

Therapeutic Solutions International's annual shares outstanding increased from Dec. 2022 (2,617.39 Mil) to Dec. 2023 (3,802.67 Mil). It means Therapeutic Solutions International issued new shares from Dec. 2022 to Dec. 2023 .


Therapeutic Solutions International  (OTCPK:TSOI) Shares Outstanding (EOP) Explanation

A company may buy back shares or issue shares in any fiscal period. If a company buys back shares, we should observe that the total number of shares decline. If the company issues new shares, the number of shares outstanding increases.

Usually the presence of treasury shares and a history of buyback are good indicators that company has competitive advantage. But studies have shown that companies usually buy back at wrong time. Buying back shares below its intrinsic value increases value for remaining shareholders. Buying back overvalued shares destroys value for existing shareholders.


Be Aware

Warren Buffett looks for consistency and upward long term trend. Because of share repurchase it is possible for net earnings trend to differ from EPS trend. He preferred net income over EPS. The companies with durable competitive advantage companies report higher % net earnings to total revenues.

Important: If a company is showing net earnings history greater than 20% on total revenues, it is probably benefiting from a long term competitive advantage.

If net earnings is less than 10%, likely to be in a highly competitive business.


Therapeutic Solutions International Shares Outstanding (EOP) Related Terms


Therapeutic Solutions International Shares Outstanding (EOP) Historical Data

* Premium members only.

The historical data trend for Therapeutic Solutions International's Shares Outstanding (EOP) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therapeutic Solutions International Shares Outstanding (EOP) Chart

Therapeutic Solutions International Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shares Outstanding (EOP)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,614.63 2,233.74 2,311.12 2,617.39 3,802.67

Therapeutic Solutions International Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Shares Outstanding (EOP) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3,450.67 3,802.67 4,230.12 4,659.02 5,057.15

TSOI vs BPTH, RGBP, HEPA: Shares Outstanding (EOP) Comparison

For the Biotechnology subindustry, Therapeutic Solutions International's Shares Outstanding (EOP), along with its competitors' market caps and Shares Outstanding (EOP) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Therapeutic Solutions International Shares Outstanding (EOP) vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Therapeutic Solutions International's Shares Outstanding (EOP) distribution charts can be found below:

* The bar in red indicates where Therapeutic Solutions International's Shares Outstanding (EOP) falls into.



Therapeutic Solutions International Shares Outstanding (EOP) Calculation

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. They have voting rights and represent ownership in the corporation by the person that holds the shares. They should be distinguished from treasury shares, which are shares held by the corporation itself, having no exercisable rights.

Shares outstanding can be calculated as either basic or fully diluted. The fully diluted shares outstanding count includes diluting securities, such as options, warrants or convertibles.

Please note: GuruFocus named Shares Outstanding (EOP) is the shares for that end of period. It is usually used to calculate balance sheet related items, such as Book Value per Share, etc. While Shares Outstanding (Diluted Average) and Shares Outstanding (Basic Average) are the weighted average shares over a period of time (a year, a quarter, or so). They are usually used to calculate income statement or cashflow statement related items, such as Earnings per Share (Diluted), etc.

What does a Shares Outstanding (EOP) of 5,057.15 Mil mean?
Therapeutic Solutions International (TSOI) has a Shares Outstanding (EOP) of 5,057.15 Mil as of Sep. 2024. The total shares a company has outstanding, at period-end. View historical data on Therapeutic Solutions International and its competitors.
Is Therapeutic Solutions International's Shares Outstanding (EOP) too high?
Therapeutic Solutions International's current Shares Outstanding (EOP) is 5,057.15 Mil.
How does Therapeutic Solutions International's Shares Outstanding (EOP) compare to BPTH and RGBP?
Therapeutic Solutions International's Shares Outstanding (EOP) of 5,057.15 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Shares Outstanding (EOP) for a Biotechnology company?
A good Shares Outstanding (EOP) depends on the Biotechnology industry context. However, Shares Outstanding (EOP) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Shares Outstanding (EOP) mean?
A high Shares Outstanding (EOP) can signal that a stock is expensive relative to its fundamentals. The total shares a company has outstanding, at period-end. View historical data on Therapeutic Solutions International and its competitors. Therapeutic Solutions International's current Shares Outstanding (EOP) is 5,057.15 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Therapeutic Solutions International stock overvalued right now?
Therapeutic Solutions International (TSOI) has a current Shares Outstanding (EOP) of 5,057.15 Mil. The current Shares Outstanding (EOP) is 5,057.15 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Shares Outstanding (EOP) calculated?
Shares Outstanding (EOP) is calculated from a company's financial statements. For Therapeutic Solutions International (TSOI), the current Shares Outstanding (EOP) is 5,057.15 Mil as of Sep. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Therapeutic Solutions International Business Description

Address 701 Wild Rose Lane, Elk City, ID, USA, 83525
Therapeutic Solutions International Inc focuses on immune modulation for the treatment of several specific diseases. It is engaged in developing a range of immune-modulatory agents to target certain cancers, improve maternal and fetal health, fight periodontal disease, and for daily health. The business divisions of the company are Nutraceutical Division which produces nutraceuticals. Its current product, QuadraMune, is a patented synergistic blend of pterostilbene, sulforaphane, epigallocatechingallate, and thymoquionone. Cellular Division obtained exclusive rights to a patented adult stem cell for the development of therapeutics in the area of chronic traumatic encephalopathy and traumatic brain injury and Lung Pathology.